Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07439042 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Buspirone for Anxiety in Autistic Youth

StatusRecruiting
PhasePhase 4
Started
View on ClinicalTrials.gov ↗

Record History

  1. Recruitment opened Study sites: 0 to 1 · Eligibility criteria expanded, about 17 words · Secondary endpoints: details revised at 3 of 3 entries Show 3 more changesShow less
    • Study sites: 0 to 1
    • Eligibility criteria expanded, about 17 words
    • Secondary endpoints: details revised at 3 of 3 entries
  2. Start date: Aug 2026 to Sep 2026v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of the study is to do a preliminary trial to determine if buspirone is effective, safe, and tolerable in autistic youth with anxiety.
Trial Details
NCT Number NCT07439042
Lead Sponsor Massachusetts General Hospital
Conditions Anxiety, Autism Spectrum Disorder
Enrollment 20 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov